Goldman Sachs Group Inc. reissued their buy rating on shares of GlaxoSmithKline plc (LON:GSK) in a report released on Tuesday morning. Goldman Sachs Group Inc. currently has a GBX 1,800 ($23.50) target price on the stock.
Other equities research analysts have also issued reports about the stock. Shore Capital reiterated a hold rating on shares of GlaxoSmithKline plc in a report on Wednesday, July 27th. Morgan Stanley set a GBX 1,500 ($19.58) price target on shares of GlaxoSmithKline plc and gave the company a neutral rating in a report on Tuesday, May 31st. Deutsche Bank AG reiterated a hold rating and set a GBX 1,700 ($22.19) price target on shares of GlaxoSmithKline plc in a report on Thursday, July 28th. Jefferies Group upgraded shares of GlaxoSmithKline plc to a buy rating and upped their price target for the company from GBX 1,650 ($21.54) to GBX 2,000 ($26.11) in a report on Thursday, July 14th. Finally, BNP Paribas reiterated a neutral rating and set a GBX 1,430 ($18.67) price target on shares of GlaxoSmithKline plc in a report on Sunday, July 3rd. Three analysts have rated the stock with a sell rating, sixteen have given a hold rating and eight have assigned a buy rating to the stock. The stock has an average rating of Hold and a consensus price target of GBX 1,676.44 ($21.88).
GlaxoSmithKline plc (LON:GSK) opened at 1645.00 on Tuesday. The stock’s 50 day moving average is GBX 1,652.33 and its 200-day moving average is GBX 1,532.89. GlaxoSmithKline plc has a one year low of GBX 1,227.50 and a one year high of GBX 1,716.50. The firm’s market capitalization is GBX 79.96 billion.
The firm also recently disclosed a dividend, which will be paid on Thursday, October 13th. Stockholders of record on Thursday, August 11th will be paid a GBX 19 ($0.25) dividend. This represents a dividend yield of 1.12%. The ex-dividend date of this dividend is Thursday, August 11th.
In other news, insider Slaoui,Moncef bought 28 shares of the firm’s stock in a transaction on Friday, August 12th. The shares were bought at an average price of GBX 2,208 ($28.82) per share, for a total transaction of £618.24 ($807.00). Also, insider Witty,Sir Andrew P sold 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, July 27th. The stock was sold at an average price of GBX 1,693 ($22.10), for a total transaction of £169,300 ($220,989.43).
GlaxoSmithKline plc Company Profile
GlaxoSmithKline plc (GSK) is a healthcare company. The Company is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. The Company’s segments include Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare.
Receive News & Ratings for GlaxoSmithKline plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline plc and related companies with MarketBeat.com's FREE daily email newsletter.